Details for New Drug Application (NDA): 220524
The generic ingredient in DEFLAZACORT is deflazacort. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the deflazacort profile page.
Summary for 220524
| Tradename: | DEFLAZACORT |
| Applicant: | Hikma |
| Ingredient: | deflazacort |
| Patents: | 0 |
Pharmacology for NDA: 220524
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 220524
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEFLAZACORT | deflazacort | TABLET;ORAL | 220524 | ANDA | Hikma Pharmaceuticals USA Inc. | 0054-0824 | 0054-0824-25 | 100 TABLET in 1 BOTTLE (0054-0824-25) |
| DEFLAZACORT | deflazacort | TABLET;ORAL | 220524 | ANDA | Hikma Pharmaceuticals USA Inc. | 0054-0825 | 0054-0825-13 | 30 TABLET in 1 BOTTLE (0054-0825-13) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 6MG | ||||
| Approval Date: | Sep 18, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 18MG | ||||
| Approval Date: | Sep 18, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 30MG | ||||
| Approval Date: | Sep 18, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
